Pharma & Biotech
-
After Four Long Years, Plymouth Meeting-Based Braeburn Receives FDA Clearance for Opioid Use Disorder Drug
Braeburn, which is based in Plymouth Meeting, has received Food and Drug Administration marketing clearance for its opioid use disorder drug Brixadi four years after being given tentative approval, writes John George for the Philadelphia Business Journal. Brixadi was approved as an extended-release, injection medication that can be administered in either weekly or monthly doses.…
-
Serb Pharmaceuticals Plans to Hire Employees at West Conshohocken HQ
Serb Pharmaceuticals plans to bring jobs to Montgomery County. The Belgium-based company acquired the rights to a blood-clotting reversal drug after the previous developer, PhaseBio was sued. The company plans to onboard 100 employees this year, with a substantial number of them in its West Conshohocken office. Serb was created after three companies,…
-
King of Prussia’s Center for Breakthrough Medicines Leverages Innovative Tech: ‘It’s Like Science Fiction’
King of Prussia-based Center for Breakthrough Medicines, along with its Discovery Labs, has become a symbol for the rapid rise of life sciences in the Philadelphia region, reported Malcolm Burnley for Philadelphia Magazine. The “gizmos” found inside the complex bring to mind something that many would expect to see in a futuristic movie: Not only…
-
Audubon Medical Device Maker Finds Patience Is a Virtue when Courting San Diego Firm
Corporate leaders at Globus Medical in Audubon first floated acquisition overtures to NuVasive — a San Diego competitor of sorts in spinal surgery technology — in 2021. But the latter turned out to be harder to entice than first thought. Its reticence, however, as seemingly been overcome, as John George reported in the Philadelphia Business…
-
French Supplier of Pharmaceutical Starch Products Opens $25 Million Center in Spring House
Roquette, a French supplier of pharmaceutical-use starches, has opened at $25 million “innovation center” in Spring House. John George reported the expansion in the Philadelphia Business Journal. Roquette’s plant-based product line includes natural fillers that ease the swallowing of tablet medications for consumers. The 23,000-square-foot space features a series of small research and development labs.…
-
Mid-Stage Trials Show Some Promise for Merck’s Experimental Cancer Vaccine
An experimental cancer vaccine is being developed by Lansdale-centric Merck, with input from Moderna. The project’s mid-stage trials are showing promise in preventing relapses in melanoma patients, reported Brianna Abbott for The Wall Street Journal. The results demonstrated progress for the two companies toward creating an injection that could ward off cancer by jump-starting the…
-
King of Prussia Healthcare-Tech Company Sees Rise in Women Applicants, Confirming Industry Trend
A new study prepared by the Chamber of Commerce of Greater Philadelphia found that the number of jobs in the Philadelphia region’s life sciences industry held by women is growing at a faster rate than those held by men. John George reported the trend in the Philadelphia Business Journal. The Center for Breakthrough Medicines in…
-
Montco Pharma Manager Named to 2023 List of Supply-Chain’s Youngest, Strongest Links
The Institute for Supply Management (ISM), a Tempe, Arizona., supply-chain organization, recognized Lansdale Johnson & Johnson R&D procurement category manager Karen Burlingame as one of its 30-Under-30 standouts. Investors Observer carried the news. In assessing the 2022–2023 industry standouts, Thomas W. Derry, ISM Chief Executive Officer, said, “The accomplishments and talents of this group are…
-
Horsham Overseer of Safe Medication Practices Issues Guidance for Pharmacists
Horsham’s Institute for Safe Medication Practices (ISMP) has developed a specific, consensus-bases set of guidelines to increase the safety rate of U.S. pharmacies. Investment insights publisher Morningstar reported the new best-practice recommendations. The increased oversight is being directed primarily at neighborhood pharmacies; however, its scope also includes: “Many types of errors recur in community pharmacies,…
-
Souderton Pharma-Service Company Invests $65 Million in Expansion for Supply-Chain Improvements
Pharmaceutical service provider Almac Group has announced an expansion of its North American headquarters in Souderton. Harold Brubaker, in the Philadelphia Business Journal, warmed up to the assignment of reporting its investment in expanded cold-room facilities. Almac Group, centered in Northern Ireland, aids pharmaceutical manufacturers in conducting clinical trials, a line of business that has…
-
Harleysville Maker of Coatings to Ease Pill Swallowing Acquires French Packaging Firm
Colorcon, the Harleysville pharmaceutical coatings supplier, has completed the acquisition of Airnov Healthcare Packaging, Inc. BioSpace announced the particulars of the deal. Colorcon creates the micro-thin coatings for tablets and capsules to ease the oral administration of pharmaceuticals. Airnov specializes in packaging that protects products such as medications from damage by exposure to moisture or…
-
AmerisourceBergen, Conshohocken, Rebrands with Name Change
Conshohocken-based AmerisourceBergen, Pennsylvania’s largest corporation, is rebranding. The publicly traded drug-shipping company will now be going by the name Cencora, reported Michael Tanenbaum for PhillyVoice. The company is known for shipping COVID-19 vaccines around the world. Inversely, it’s faced criticism for its distribution of opioids and has agreed to pay $6.1 billion in settlements. So…
-
Conshohocken-based Madrigal Pharmaceuticals’ Shares Skyrocket Following Liver Disease Clinical Trial
Conshohocken-based Madrigal Pharmaceuticals saw its shares leap in value after the company reported additional positive late-stage clinical trial data for its experimental non-alcoholic steatohepatitis (NASH) treatment, called “resmetirom.” John George reported the positive development for the Philadelphia Business Journal. NASH is an inflammatory disease characterized by the accumulation of liver fat in people who do…
-
Merck Skin Cancer mRNA Vaccine Shows Promising Results in Initial Trials
Merck, the pharmaceutical giant with sizable operations in West Point outside of Lansdale, and Moderna have announced promising results from a skin cancer mRNA vaccine on which they are collaborating. A staff report from The Telegraph in London covered the joint progress. The vaccine utilizes the same mRNA technology first used in COVID-19 vaccines. It…
-
School Sleuths: Methacton School District Deepens STEM Courses with Donation from Ambler Savings Bank
Methacton School District students looking to launch a crime scene investigation career, à la television’s CSI and its many spinoffs, can now prep for it in a STEM-centric onsite forensic lab. The new educational asset was made possible in part by a donation from Ambler Savings Bank. The lab widens the roster of coursework the…
-
Biopharma Ingredients Manufacturing Plant Opens in King of Prussia: ‘There Are Customers Waiting’
Ecolab, Inc., a St. Paul. Minn., pharmaceutical ingredients manufacturing plant, cut the ribbon recently on a new factory in King of Prussia. Harold Brubaker covered the venture in The Philadelphia Inquirer. The $3.7 billion Ecolab acquisition of Purolite was a strategic decision to spur growth in both the traditional-drug and faster-growing pharmaceutical industries. Ecolab intends…
-
Plymouth Meeting Firm Tests Liver Disease Gene Therapy; Trials Target the Condition in Babies
A gene-therapy regimen designed to treat liver disease is being tested on babies at iECURE, a Plymouth Meeting-based biopharma company. Tom Avril covered the development in The Philadelphia Inquirer. The effort is being funded by $65 million in new venture capital financing, backing an idea of University of Pennsylvania scientist Jim Wilson. Wilson, iECURE’s chief…
-
Former Horsham CRE Site Being Reimagined as Think-Tank Location for Healthcare Entrepreneurs
The Horsham site of a former mail order pharmacy is being redesigned as the Center for Diagnostic Discovery, an entrepreneurial environment for healthcare innovation. John George broke the story in the Philadelphia Business Journal. The $12 million investment is the brainchild of Eric Rieders of NMS Labs in Horsham. He envisions a location in which…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
